Mamaearth shares hit upper circuit after strong Q2 show

Shares of Honasa Consumer, the parent entity of beauty and personal care brand Mamaearth, rallied 20% on Thursday, hitting its upper circuit limit, following a strong uptick in Q2 sales and a near-doubling of its profit.

Honasa shares hit an all-time high of `423.75 on Thursday, rising 28% since its recent public listing. The company reported a 93% year-on-year jump in its net profit to `29 crore in July-September, while revenue from operations grew 21% to `496 crore.

Though the company’s IPO performance was a dampener, debuting at only a 2% premium, its Q2 earnings showed strong volume growth year-on-year and a larger offline distribution network, pleasing analysts and investors alike.

Ola Electric shares hit 20% upper circuit after HSBC initiates coverage with ‘Buy’ Mining stocks NMDC, Vedanta, Hind Zinc, MOIL, Coal India plunge as much as 5% after SC allows states to collect past dues on royalties Power-sector NBFCs sees “no impact” of rising yen on debt costs Tata Power looking at new thermal projects, says CEO Sinha

Also Read

Coca-Cola India enters ready-to-drink tea beverages segment

“Honasa Consumer has been a notable outlier among digital-first BPC brands in India, from the standpoint of scale, profitability and capital efficiency. We expect it to deliver a sector-leading revenue growth over the coming years, coupled with improving profitability,” Jefferies said in a note.

Encouraged by the strong growth, the brokerage hiked its estimates for Ebitda and earnings per share for the next two financial years by 5-6%. It now expects the FY24 Ebitda to be `131.6 crore on a revenue of `1,963.4 crore. Earnings are expected at `2.99 per share.

Also Read

Zappfresh raises Rs 30cr from investors to grow business

Honasa currently has six brands under its portfolio, including Mamaearth, The Derma Co, Aqualogica, Dr Sheth’s and Bblunt.

While the company does not disclose revenue growth in all its brands separately, it noted that the Mamaearth brand grew by double digits in the first half of this year.

“Among new brands, The Derma Co is now at an annual revenue run-rate (ARR) of `380 crore and Aqualogica is at `180 crore. Dr Sheth became the fourth brand to cross `150-crore ARR, growing 30x since acquisition,” the brokerage said.

Related Posts

Mehta Equities’ top recommendation for the week include Varroc Engineering and Bajel Projects

By Riyank Arora On Wednesday, the benchmark index opened with a neutral opening and rose by nearly 146 points by the close. The Nifty ended 146 points…

Key IPOs to watch this week- Companies collectively aim to raise over Rs 7,300 crore

Six companies are set to make a splash on Dalal Street, collectively aiming to raise over Rs 7,300 crore through initial public offerings (IPOs). Among these, Tata…

Paytm shares hit lifetime low after Macquarie cuts rating

Shares of Paytm parent One97 Communications on Tuesday fell 10% to a lifetime low of Rs 380.15 on the National Stock Exchange after brokerage firm Macquarie Capital…

RBI’s interest rate decision, macro data, global factors to dictate mkt trends this week- Analysts

The Reserve Bank of India’s interest rate decision, macroeconomic data and global trends will drive investors’ sentiment this week, with markets hoping to continue the positive momentum…

SEBI to introduce ASBA-like facility for secondary market trading from Jan-Feb

To safeguard investors’ money from misuse, an ASBA-like facility for trading in secondary markets will be available from January or February, Sebi chief Madhabi Puri Buch said…

Sanstar makes positive debut on NSE, lists at 14.7% premium; Here are all other details

Sanstar listed at Rs 109, a premium of 14.7% to the issue price on the National Stock Exchange.  The company opened its IPO to investors on July…